Construction and performance evaluation of Hep/silk-PLCL composite nanofiber small-caliber artificial blood vessel graft

Haizhu Kuang,Yao Wang,Yu Shi,Wangchao Yao,Xi He,Xuezhe Liu,Xiumei Mo,Shuyang Lu,Peng Zhang

DOI: https://doi.org/10.1016/j.biomaterials.2020.120288

IF: 14

2020-11-01

Biomaterials

Abstract:<p>To meet the growing clinical demand for small-caliber blood vessel grafts to treat cardiovascular diseases, it is necessary to develop safe and long-term unobstructed grafts. In this study, a biodegradable graft made of composite nanofibers is introduced. A composite nanofiber core-shell structure was prepared by a combination of conjugate electrospinning and freeze-dry technology. The core fiber was poly(<span class="small-caps">l</span>-lactide-co-caprolactone) (PLCL)-based and the core fibers were coated with heparin/silk gel, which acted as a shell layer. This special structure in which the core layer was made of synthetic materials and the shell layer was made of natural materials took advantage of these two different materials. The core PLCL nanofibers provided mechanical support during vascular reconstruction, and the shell heparin/silk gel layer enhanced the biocompatibility of the grafts. Moreover, the release of heparin in the early stage after transplantation could regulate the microenvironment and inhibit the proliferation of intima. All of the graft materials were biodegradable and safe biomaterials, and the degradation of the graft provided space for the growth of regenerated tissue in the late stage of transplantation. Animal experiments showed that the graft remained unobstructed for more than eight months <em>in vivo</em>. In addition, the regenerated vascular tissue provided a similar function to that of autogenous vascular tissue when the graft was highly degraded. Thus, the proposed method produced a graft that could maintain long-term patency <em>in vivo</em> and remodel vascular tissue successfully.</p>

engineering, biomedical,materials science, biomaterials

What problem does this paper attempt to address?

This paper attempts to address the issue of long-term patency in small-diameter artificial vascular grafts for the treatment of cardiovascular diseases. Specifically, the study aims to develop a composite nanofiber small-diameter artificial vascular graft with excellent biocompatibility, hemocompatibility, and degradability to meet clinical needs. This graft can maintain long-term patency in vivo and successfully promote vascular tissue regeneration.

### Main Issues:
1. **Clinical Demand**: With the increasing number of cardiovascular disease patients, the demand for small-diameter artificial vascular grafts is also growing. Existing autologous vascular grafts have issues with quality assurance and high postoperative complications, necessitating the development of new small-diameter artificial vascular grafts.
2. **Long-term Patency**: An ideal graft should have good biocompatibility, hemocompatibility, and degradability, and provide mechanical support matching that of autologous vessels to promote tissue regeneration in vivo.
3. **Material Selection**: Synthetic polymers and natural materials each have their advantages and disadvantages. Combining the strengths of these two materials is a key issue. While synthetic polymers have excellent mechanical properties, they are prone to thrombosis, intimal hyperplasia, calcification, and chronic inflammation. On the other hand, natural materials have good biocompatibility but poor mechanical properties, leading to vascular dilation and aneurysms.
4. **Early and Late Effects**: Most existing studies focus on the effective anticoagulation and patency rates in the early stages of graft implantation. However, excessive proliferation of smooth muscle cells in the late stages can lead to restenosis, affecting the long-term patency of the graft.

### Solutions:
1. **Composite Nanofiber Structure**: A composite nanofiber with a core layer of PLCL nanofibers and a shell layer of heparin/silk fibroin gel was prepared using co-electrospinning and freeze-drying techniques. This structure combines the advantages of synthetic and natural materials, providing mechanical support while enhancing biocompatibility and hemocompatibility.
2. **Role of Heparin**: Heparin not only has anticoagulant properties but also promotes endothelial cell proliferation and inhibits smooth muscle cell proliferation, helping to regulate the vascular microenvironment post-implantation and suppress intimal hyperplasia.
3. **Degradability**: All graft materials are degradable biomaterials, providing space for the growth of regenerative tissue during degradation, ensuring the performance of the graft in the late stages.
4. **Animal Experiment Validation**: Animal experiment results show that the graft can maintain patency for over 8 months in vivo, and after significant degradation, the regenerated vascular tissue functions similarly to autologous vascular tissue.

Through these methods, the research team successfully developed a small-diameter artificial vascular graft that can maintain long-term patency in vivo and successfully promote vascular tissue regeneration.